Abstract: A deformation sensing sensor as disclosed includes a conductive material inside the body thereof such that, by sensing a change in resistance or capacitance resulting from a deformation, a degree of deformation of the measurement object can be detected. The body includes an elastic layer, which has a corrugation formed on one surface thereof, and a conductive layer, which is formed on the other surface of the elastic layer using a conductive material. When the body is deformed in the lateral direction of the surface on which the corrugation is formed, the change in resistance of the conductive layer before and after the deformation, or the change in capacitance thereof is measured, thereby detecting the degree of deformation of the measurement object.

Abstract: A deformation sensing sensor as disclosed includes a conductive material inside the body thereof such that, by sensing a change in resistance or capacitance resulting from a deformation, a degree of deformation of the measurement object can be detected. The body includes an elastic layer, which has a corrugation formed on one surface thereof, and a conductive layer, which is formed on the other surface of the elastic layer using a conductive material. When the body is deformed in the lateral direction of the surface on which the corrugation is formed, the change in resistance of the conductive layer before and after the deformation, or the change in capacitance thereof is measured, thereby detecting the degree of deformation of the measurement object.

Abstract: The present invention relates to an eco-friendly probiotic composition, and more particularly, to a probiotic composition for livestock production, comprising a lactic acid bacteria culture medium and an organic acid, wherein the organic acid is contained in an amount of 0.002 to 0.1 parts by weight relative to 1 parts by weight of the lactic acid bacteria culture medium. The present invention also relates to a method for preparing the composition. The eco-friendly probiotic composition of the present invention does not contain antibiotics and may exhibit complex effect of sterilization and virucidal effectiveness.

Abstract: This invention relates to a bacteriophage MPK6 (deposit number: KCCM 11044P) having a lytic activity to Pseudomonas aeruginosa, or a progeny bacteriophage thereof having a RFLP (Restriction fragment length polymorphism) DNA profile substantially equivalent to the bacteriophage MPK6. The present invention provides a bacteriophage MPK6 or a progeny bacteriophage thereof capable of treating a Pseudomonas aeruginosa infection disease, and suggests an anti-bacterial activity of MPK6 and its progeny bacteriophage using a mammalian and non-mammalian infection model. According to the present invention, the present bacteriophage MPK6 or progeny bacteriophage thereof represents very effective efficacy on treatment of P. aeruginosa-induced peritonitis-sepsis.

Abstract: This invention relates to a bacteriophage MPK6 (deposit number: KCCM 11044P) having a lytic activity to Pseudomonas aeruginosa, or a progeny bacteriophage thereof having a RFLP (Restriction fragment length polymorphism) DNA profile substantially equivalent to the bacteriophage MPK6. The present invention provides a bacteriophage MPK6 or a progeny bacteriophage thereof capable of treating a Pseudomonas aeruginosa infection disease, and suggests an anti-bacterial activity of MPK6 and its progeny bacteriophage using a mammalian and non-mammalian infection model. According to the present invention, the present bacteriophage MPK6 or progeny bacteriophage thereof represents very effective efficacy on treatment of P. aeruginosa-induced peritonitis-sepsis.